Patents by Inventor Kenneth Newlander

Kenneth Newlander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Indazoles
    Patent number: 9018382
    Abstract: Herein are disclosed indazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Grant
    Filed: August 13, 2014
    Date of Patent: April 28, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: Celine Duquenne, Neil Johnson, Steven D. Knight, Louis LaFrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • Indoles
    Patent number: 8975291
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: March 10, 2015
    Assignee: GlaxoSmithKline LLC
    Inventors: James Brackley, III, Joelle Lorraine Burgess, Seth Grant, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • INDAZOLES
    Publication number: 20140350013
    Abstract: Herein are disclosed indazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: August 13, 2014
    Publication date: November 27, 2014
    Inventors: Celine DUQUENNE, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • Indazoles
    Patent number: 8846935
    Abstract: Herein are disclosed indazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: September 30, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Celine Duquenne, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • Azaindazoles
    Patent number: 8637509
    Abstract: Herein are disclosed azaindazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: January 28, 2014
    Assignee: GlaxoSmithKline LLC
    Inventors: Joelle Lorraine Burgess, Neil Johnson, Steven D. Knight, Louis LaFrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma, Dominic Suarez
  • INDOLES
    Publication number: 20130345200
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: August 7, 2013
    Publication date: December 26, 2013
    Applicant: GlaxoSmithKline LLC
    Inventors: James Brackley, III, Joelle Lorraine Burgess, Seth Grant, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • AZAINDAZOLES
    Publication number: 20130059849
    Abstract: Herein are disclosed azaindazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: May 5, 2011
    Publication date: March 7, 2013
    Inventors: Joelle Lorraine Burgess, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma, Dominic Suarez
  • INDOLES
    Publication number: 20130053397
    Abstract: Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful in treating cancer.
    Type: Application
    Filed: May 5, 2011
    Publication date: February 28, 2013
    Inventors: James Brackley, III, Joelle Lorraine Burgess, Seth Grant, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • INDAZOLES
    Publication number: 20130053383
    Abstract: Herein are disclosed indazoles of formula (I) where the various groups are defined herein, and which are useful for treating cancer.
    Type: Application
    Filed: May 5, 2011
    Publication date: February 28, 2013
    Inventors: Celine Duquenne, Neil Johnson, Steven D. Knight, Louis Lafrance, William H. Miller, Kenneth Newlander, Stuart Romeril, Meagan B. Rouse, Xinrong Tian, Sharad Kumar Verma
  • System and method for real-time network-based recovery following an information warfare attack
    Patent number: 7698738
    Abstract: A method, and a corresponding apparatus, provide for real-time network-based recovery from information warfare (IW) attacks on a network that includes subnets, with each subnet including one or more nodes. The method includes executing a pre-IW attack routine to identify IW attack recovery information, in response to an IW attack, executing an IW attack response routine, and executing a real-time network-based recovery routine. The pre-IW attack routine includes monitoring conditions on the network and at each of the subnets and nodes. When an IW attack occurs at an entity in the network, a condition flags are set to indicate the specific entity or entities being attacked. A condition flag set to 0 implies full operational capability of the entity, a condition flag set to 1 implies recent IW attack or IW attack in progress at the entity, and a condition flag set to 2 implies recovery of the entity from the IW attack.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: April 13, 2010
    Assignee: Northrop Grumman Systems Corporation
    Inventors: Dennis Hain McCallam, Ronald Kenneth Newland
  • Real-time recovery of compromised information
    Patent number: 7441275
    Abstract: An apparatus and a corresponding method provide for real-time recovery of compromised information in a computer network. The method includes analyzing data objects in the computer network to determine data objects that comprise minimal essential information, collecting the minimal essential information, and storing the minimal essential information. To limit potential exposure of the minimal essential information, the stored minimal essential information is hidden in the computer network.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: October 21, 2008
    Assignee: Northrop Grumman Corporation
    Inventors: Dennis Hain McCallam, Ronald Kenneth Newland
  • AZAINDOLE INHIBITORS OF AURORA KINASES
    Publication number: 20080081808
    Abstract: The present invention relates to a compound represented by Formula (I): and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.
    Type: Application
    Filed: September 14, 2007
    Publication date: April 3, 2008
    Inventors: Martha Sarpong, Nicholas Adams, Jeffrey Axten, Amita Chaudhari, Dashyant Dhanak, Toshihiro Hamajima, Kenneth Newlander, Cynthia Parrish, Jerry Adams, Domingos Silva, Jun Tang
  • AZAINDOLE INHIBITORS OF AURORA KINASES
    Publication number: 20080004308
    Abstract: The present invention relates to a compound represented by Formula (I): and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.
    Type: Application
    Filed: August 8, 2007
    Publication date: January 3, 2008
    Inventors: Dashyant Dhanak, Kenneth Newlander
  • Compounds, compositions and methods
    Publication number: 20070254870
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: April 19, 2007
    Publication date: November 1, 2007
    Inventors: Gustave Bergnes, Dashyant Dhanak, Steven Knight, Pu Lu, David Morgans, Kenneth Newlander
  • Certain chemical entities, compositions, and methods
    Publication number: 20070219192
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
    Type: Application
    Filed: November 2, 2006
    Publication date: September 20, 2007
    Inventors: Xiangping Qian, Gustave Bergnes, Kenneth Newlander, Duke Fitch, Dashyant Dhanak
  • AZAINDOLE INHIBITORS OF AURORA KINASES
    Publication number: 20070149561
    Abstract: The present invention relates to a compound represented by Formula (I): and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.
    Type: Application
    Filed: December 19, 2006
    Publication date: June 28, 2007
    Inventors: Dashyant DHANAK, Kenneth Newlander
  • Compounds, methods and compositions
    Publication number: 20070135432
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: November 15, 2006
    Publication date: June 14, 2007
    Inventors: Han-Jie Zhou, David Morgans, Gustave Bergnes, Steven Knight, Kenneth Newlander, Dashyant Dhanak, Nicholas Adams
  • Fab I inhibitors
    Publication number: 20060116394
    Abstract: Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
    Type: Application
    Filed: November 22, 2005
    Publication date: June 1, 2006
    Inventors: Walter Burgess, Dalia Jakas, William Huffman, William Miller, Kenneth Newlander, Mark Seefeld, Irene Uzinskas
  • Compounds, compositions and methods
    Publication number: 20060052360
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: December 12, 2003
    Publication date: March 9, 2006
    Inventors: Gustave Bergnes, Dashyant Dhanak, Steven Knight, Pu Lu, David Morgans, Kenneth Newlander
  • Compounds, compositions and methods
    Publication number: 20060020008
    Abstract: Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.
    Type: Application
    Filed: June 15, 2005
    Publication date: January 26, 2006
    Inventors: Andrew McDonald, Gustave Bergnes, Bainian Feng, David Morgans, Steven Knight, Kenneth Newlander, Dashyant Dhanak, Christopher Brook